by admin | Jun 30, 2025 | News & Opinions
By Antonio Pequeño IV – Forbes – Yeztugo, a twice-a-year antiviral shot to prevent HIV, was approved by the Food and Drug Administration on Wednesday, marking a major advance in battling AIDS. Key Facts The drug (which has the generic name lenacapavir)...
by admin | Jun 27, 2025 | News & Opinions
By Sant Pau Research Institute – SciTechDaily – A new antibody treatment prevents cholesterol buildup in heart mitochondria and restores energy production, offering hope for future heart disease therapies. An international team of researchers has uncovered...
by admin | Jun 26, 2025 | News & Opinions
By Stanford Report – Stanford researchers have developed a faster, more precise way to model and print vascular systems, solving a critical challenge in fabricating transplantable organs from patients’ own cells. There are more than 100,000 people on organ...
by admin | Jun 25, 2025 | News & Opinions
By Gina Kolata – New York Times – Most in a small group of patients receiving a stem cell-based infusion no longer needed insulin, but the drug may not suit those with more manageable type 1 diabetes. A single infusion of a stem cell-based treatment may...
by admin | Jun 24, 2025 | News & Opinions
By Eleanor Garth – Longevity.Technology – Leopoldina issues policy paper urging integration of geroscience into national healthcare and research infrastructure. Germany’s National Academy of Sciences Leopoldina has published a detailed policy paper calling...
by admin | Jun 23, 2025 | News & Opinions
By The Associated Press – PORTLAND, Ore. — Twenty-seven states and the District of Columbia on Monday filed a lawsuit in bankruptcy court seeking to block the sale of personal genetic data by 23andMe without customer consent. The lawsuit comes as a biotechnology...
